Document is current
Any future updates will be listed below
-
Authors
Ruiz-Iglesias, Ainhoa
Guilbaud, Emma
Galluzzi, Lorenzo
Mañes, Santos
- License Information
-
More Information
Article History
Received: 7 September 2025
Accepted: 6 October 2025
First Online: 30 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: LG is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. The other authors have no conflicts of interest to declare.
